Загрузка...
Taq1A polymorphism and medication effects on inhibitory action control in Parkinson disease
BACKGROUND: Dopamine therapy in Parkinson disease (PD) can have differential effects on inhibitory action control, or the ability to inhibit reflexive or impulsive actions. Dopamine agonist (DAAg) medications, which preferentially target D2 and D3 receptors, can either improve or worsen control of i...
Сохранить в:
| Опубликовано в: : | Brain Behav |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6043698/ https://ncbi.nlm.nih.gov/pubmed/29856137 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.1008 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|